In neuroblastomas, high ALK expression was found to be associated with ALK amplification, as well as copy number gain of the ALK locus, supporting the hypothesis that ALK expression depends upon increasing the DNA dose; thus, we could expect a superimposable feature in NSCLC. This evidence concerns the gene ALK and non-small cell lung carcinoma.